GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Awakn Life Sciences Corp (OTCPK:AWKNF) » Definitions » Common Stock

Awakn Life Sciences (Awakn Life Sciences) Common Stock : $16.07 Mil (As of Oct. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Awakn Life Sciences Common Stock?

Awakn Life Sciences's quarterly common stock increased from Apr. 2023 ($15.46 Mil) to Jul. 2023 ($16.27 Mil) but then declined from Jul. 2023 ($16.27 Mil) to Oct. 2023 ($16.07 Mil).

Awakn Life Sciences's annual common stock increased from Jan. 2021 ($0.91 Mil) to Jan. 2022 ($12.79 Mil) and increased from Jan. 2022 ($12.79 Mil) to Jan. 2023 ($14.91 Mil).


Awakn Life Sciences Common Stock Historical Data

The historical data trend for Awakn Life Sciences's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Awakn Life Sciences Common Stock Chart

Awakn Life Sciences Annual Data
Trend Jan21 Jan22 Jan23
Common Stock
0.91 12.79 14.91

Awakn Life Sciences Quarterly Data
Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 13.77 14.91 15.46 16.27 16.07

Awakn Life Sciences Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.


Awakn Life Sciences (Awakn Life Sciences) Business Description

Traded in Other Exchanges
Address
301?217 Queen Street West, Toronto, ON, CAN, M5V 0R2
Awakn Life Sciences Corp is a clinical-stage biotechnology company intended to develop therapeutics to treat addiction with a near-term focus on Alcohol Use Disorder. The Company focuses on Alcohol Use Disorder (AUD), a condition affecting the people in the US and key international markets and many people globally for which the current standard of care is inadequate, enabling to provide breakthrough therapeutics to addiction sufferers in desperate need.

Awakn Life Sciences (Awakn Life Sciences) Headlines